Cencora, Inc. 击败了Q4收入估计数,看到投资者持有的混合股票,价格目标增加到280.20美元。 Cencora, Inc. beat Q4 earnings estimates, saw mixed investor holdings, and got a price target boost to $280.20.

投资人惠灵顿管理集团有限责任公司和CIBC私人财富集团有限责任公司减少了其在Cencora公司(NYSE:COR)的股份,而DnB资产管理公司则增加了其股份。 Investors Wellington Management Group LLP and CIBC Private Wealth Group LLC have reduced their holdings in Cencora, Inc. (NYSE:COR), while DnB Asset Management AS increased its stake. Cencora报告,Q4收入为每股3.73美元。 Cencora reported Q4 earnings of $3.73 per share, beating estimates. 分析员提高了价格目标,平均为280.20美元。 Analysts have raised price targets, with an average of $280.20. 该公司分发药品和保健产品,市场上限为533.6亿美元。 The company distributes pharmaceuticals and healthcare products, with a market cap of $53.36 billion.